Skip to main content
Equibles
DOCS logo

DOCS · Doximity, Inc. · Metrics

Track DOCS — free

Use DOCS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DOCS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$32.76 -0.87 (-2.59%) At close · Oct 30 Q1 2027 earnings call transcript
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$5.84B
Shares
178.25M
Volume · Oct 30 2.2M Avg daily vol (3M) 4.4M

DOCS metrics

103 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$32.76
Market cap
$5.84B

Price action

20 metrics
Price change (1W)
-1.9%
Price change (30D)
+14.9%
Price change (3M)
+56.7%
Price change (6M)
+31.1%
Price change (YTD)
-26.0%
Price change (1Y)
-50.2%
Trailing year
Price change (5Y)
-52.8%
52-week high
$66.95
52-week low
$18.01
Change from 52-week high
-51.1%
Change from 52-week low
+81.9%
Annualized volatility
64.5%
Annualized volatility (3M)
79.7%
Beta
0.5
RSI (14D)
61.7
Price vs SMA 50
+15.8%
Price vs SMA 200
+28.2%
Avg volume (3M)
4.40M
Relative volume
0.5
Average dollar volume
$117.96M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
178.25M

Valuation

12 metrics
P / E (TTM)
39.0
Trailing earnings · reciprocal yield 2.6%
PEG ratio
—
EV / revenue
8.5×
reciprocal yield 11.8%
EV / EBITDA
26.5×
reciprocal yield 3.8%
EV / EBIT
28.7×
reciprocal yield 3.5%
P / sales
8.9×
reciprocal yield 11.2%
P / book
6.4
reciprocal yield 15.7%
FCF yield
—
TTM · current market cap
Buyback yield
6.9%
P / FCF
—
P / operating cash flow
19.1
reciprocal yield 5.2%
Earnings yield
2.9%

Historical valuation

8 metrics
P / E historical average (3Y)
41.0×
reciprocal yield 2.4%
P / E historical average (5Y)
44.0×
reciprocal yield 2.3%
EV / revenue historical average (3Y)
13.1×
reciprocal yield 7.6%
EV / revenue historical average (5Y)
14.1×
reciprocal yield 7.1%
EV / EBIT historical average (3Y)
35.8×
reciprocal yield 2.8%
EV / EBIT historical average (5Y)
41.2×
reciprocal yield 2.4%
EV / EBITDA historical average (3Y)
33.7×
reciprocal yield 3.0%
EV / EBITDA historical average (5Y)
37.8×
reciprocal yield 2.6%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
6.9%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
88.1%
Operating margin
29.6%
Trailing 12 months
Net margin
25.5%
Gross profit (TTM)
$577.34M
Operating profit (TTM)
$194.05M
Net income (TTM)
$167.05M
Trailing 12 months
Diluted EPS (TTM)
$0.84
FCF margin
—
Effective tax rate
26.2%

Per share

11 metrics
Revenue per diluted share (TTM)
$3.33
Gross profit per diluted share (TTM)
$2.93
Operating profit per diluted share (TTM)
$0.98
EBITDA per diluted share (TTM)
$1.06
Net income per diluted share (TTM)
$0.84
Operating cash flow per diluted share (TTM)
$1.55
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.73
Stock compensation per diluted share (TTM)
$0.70
Book value per share
$5.09

Growth

11 metrics
Revenue growth YoY
+7.3%
Year over year
Net income growth YoY
-54.4%
Revenue (TTM)
$655.57M
Trailing 12 months
EPS growth YoY
-51.9%
Shares change YoY
-5.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+15.5%
Revenue CAGR (5Y)
+25.5%
EPS CAGR (3Y)
+22.7%
EPS CAGR (5Y)
+33.6%
FCF CAGR (3Y)
+22.4%
FCF CAGR (5Y)
+31.6%

Quality

14 metrics
Return on equity
18.2%
Return on assets
15.4%
Debt / equity
0.0
Current ratio
6.1
EBITDA (TTM)
$209.92M
Free cash flow (TTM)
—
Quick ratio
6.1
Interest coverage
—
Net debt / EBITDA
-1.3
Return on invested capital
22.3%
Trailing 12 months
Net cash
$273.60M
Latest balance sheet
Cash & equivalents
$273.60M
Total assets
$1.08B
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$306.34M
Capital expenditures (TTM)
$62,000
R&D (TTM)
$142.38M
SG&A (TTM)
—
Stock compensation (TTM)
$136.51M
R&D / revenue
21.7%
Stock compensation / revenue
20.8%

Ownership (13F)

9 metrics
13F filers
364
13F filer change QoQ
-68
Institutional ownership
73.1%
Conviction holders (share of 13F filers)
0.3%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-3.8%
Holder tenure
11.1
Price vs estimated holder cost
-41.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
15.9%

Short interest

3 metrics
Short interest
5.1%
Latest settlement · 2.8 days to cover
Days to cover
2.8d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$666,515
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1516513 CUSIP 26622P107 13F (30d) 119 filings 102 filers Visit website Investor relations